✦ The 2031 HorizonNarrow moat

Synektik (SNT) — the future bets

Synektik's installed base is the argument for the next renewal in 2031 and the prize if Intuitive declines to renew.

Every other bet Synektik makes will be settled at one meeting: Intuitive's decision on what happens after 31 December 20311. The contract has been renewed early each time so far, and each renewal added territory23. The next one is the most valuable, because the installed base it covers is now far larger.

da Vinci systems under Synektik service37Sep 202257Sep 202386Sep 2024113Sep 2025142Jun 2026Synektik reports, 2022-2026
Nearly four times in less than four years.

Synektik's case for renewal is the size and use of that base. It had 142 authorised da Vinci systems under its service at June 20264, against 113 at September 20255 and 37 at September 20226. Polish procedures rose 67% in the year to September 20257. A distributor that grew the market that fast is hard to fault.

Intuitive's case for going direct is the same base. The more robots in a territory, the more instrument and service revenue it could keep for itself. In March 2026 it paid about $533,1 million to do that in Italy, Spain and Portugal8.

The trajectory Intuitive will be looking at is steep. Robots under Synektik's care rose from 113 to 142 in nine months910, and trailing recurring revenue from 284,0 million złoty to 374,7 million złoty in a year11.

The installed base under Synektik's service is both the argument for renewal and the prize if Intuitive decides otherwise. What counts is how large it is when the question is next asked.

Moat trajectory: Holding steady

Term extended to 2031 in February 2026.

The number that tests this moat
Reported
da Vinci systems under Synektik service
142 at June 2026 (113 at September 2025)

The base Intuitive will weigh at the next renewal.

Source: Synektik interim report, nine months to June 2026 ↗
References
  1. ReportedEvery other bet Synektik makes will be settled at one meeting: Intuitive's decision on what happens after 31 December 2031.
    Synektik interim financial statements for 1 October - 31 December 2025 - including the annex extending the da Vinci distribution agreement to 31 December 2031 and adding Ukraine, and the 10,75 złoty dividend. — October - December 2025 · publ. February 2026 · source ↗
  2. ReportedThe contract has been renewed early each time so far, and each renewal added territory.
    Synektik annual management board report for the fiscal year to 30 September 2025 - financial review: margins, net debt, return on equity, working capital and deferred income. — October 2024 - September 2025 · publ. December 2025 · source ↗
  3. ReportedThe contract has been renewed early each time so far, and each renewal added territory.
    Synektik interim financial statements for 1 October - 31 December 2025 - including the annex extending the da Vinci distribution agreement to 31 December 2031 and adding Ukraine, and the 10,75 złoty dividend. — October - December 2025 · publ. February 2026 · source ↗
  4. ReportedIt had 142 authorised da Vinci systems under its service at June 2026, against 113 at September 2025 and 37 at September 2022.
    Synektik S.A. and Synektik Group interim condensed financial statements for 1 October 2025 - 30 June 2026 (third quarter of the fiscal year) - management commentary: orders, backlog, da Vinci systems and procedures, recurring revenue, radiopharmaceutical sales and seasonality. — October 2025 - June 2026 · publ. 5 August 2026 · source ↗
  5. ReportedIt had 142 authorised da Vinci systems under its service at June 2026, against 113 at September 2025 and 37 at September 2022.
    Synektik annual management board report for the fiscal year to 30 September 2025 - operating review: da Vinci systems and procedures, orders, recurring revenue, radiopharmaceutical products and the Baltic expansion. — October 2024 - September 2025 · publ. December 2025 · source ↗
  6. ReportedIt had 142 authorised da Vinci systems under its service at June 2026, against 113 at September 2025 and 37 at September 2022.
    Synektik interim report for the fiscal year to 30 September 2022 - revenue, segments, installed base in Poland, Czechia and Slovakia, the first dedicated reimbursement and example tenders. — October 2021 - September 2022 · publ. November 2022 · source ↗
  7. ReportedPolish procedures rose 67% in the year to September 2025.
    Synektik annual management board report for the fiscal year to 30 September 2025 - operating review: da Vinci systems and procedures, orders, recurring revenue, radiopharmaceutical products and the Baltic expansion. — October 2024 - September 2025 · publ. December 2025 · source ↗
  8. ReportedIn March 2026 it paid about $533,1 million to do that in Italy, Spain and Portugal.
    Intuitive Surgical Form 10-Q, quarter ended June 30, 2026 (installed base 11 710 da Vinci systems up 12%; the 1 March 2026 acquisition of the da Vinci and Ion distribution businesses of ab medica, Abex and Excelencia Robótica for approximately $533,1 million in cash, with $279,8 million of intangible and other assets and $218,0 million of goodwill, making Intuitive the direct distributor in Italy, Spain and Portugal). Same document as Intuitive's own _IS_Q226 record. — Q2 2026 and the first six months · publ. July 21, 2026 · source ↗
  9. ReportedRobots under Synektik's care rose from 113 to 142 in nine months, and trailing recurring revenue from 284,0 million złoty to 374,7 million złoty in a year.
    Synektik annual management board report for the fiscal year to 30 September 2025 - operating review: da Vinci systems and procedures, orders, recurring revenue, radiopharmaceutical products and the Baltic expansion. — October 2024 - September 2025 · publ. December 2025 · source ↗
  10. ReportedRobots under Synektik's care rose from 113 to 142 in nine months, and trailing recurring revenue from 284,0 million złoty to 374,7 million złoty in a year.
    Synektik S.A. and Synektik Group interim condensed financial statements for 1 October 2025 - 30 June 2026 (third quarter of the fiscal year) - management commentary: orders, backlog, da Vinci systems and procedures, recurring revenue, radiopharmaceutical sales and seasonality. — October 2025 - June 2026 · publ. 5 August 2026 · source ↗
  11. ReportedRobots under Synektik's care rose from 113 to 142 in nine months, and trailing recurring revenue from 284,0 million złoty to 374,7 million złoty in a year.
    Synektik S.A. and Synektik Group interim condensed financial statements for 1 October 2025 - 30 June 2026 (third quarter of the fiscal year) - management commentary: orders, backlog, da Vinci systems and procedures, recurring revenue, radiopharmaceutical sales and seasonality. — October 2025 - June 2026 · publ. 5 August 2026 · source ↗
Sources
Generated September 24, 2026